These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34023250)

  • 1. Multimodality Imaging Assessment of Myocardial Fibrosis.
    Gupta S; Ge Y; Singh A; Gräni C; Kwong RY
    JACC Cardiovasc Imaging; 2021 Dec; 14(12):2457-2469. PubMed ID: 34023250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic late gadolinium enhancement cardiac magnetic resonance for diagnosing myocardial scar.
    Abdula G; Nickander J; Sörensson P; Lundin M; Kellman P; Sigfridsson A; Ugander M
    Scand Cardiovasc J; 2018 Jun; 52(3):127-132. PubMed ID: 29544374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial Tissue Characterization and Fibrosis by Imaging.
    Karamitsos TD; Arvanitaki A; Karvounis H; Neubauer S; Ferreira VM
    JACC Cardiovasc Imaging; 2020 May; 13(5):1221-1234. PubMed ID: 31542534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac MRI: a central prognostic tool in myocardial fibrosis.
    Ambale-Venkatesh B; Lima JA
    Nat Rev Cardiol; 2015 Jan; 12(1):18-29. PubMed ID: 25348690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of myocardial fibrosis with T1 mapping MRI.
    Everett RJ; Stirrat CG; Semple SI; Newby DE; Dweck MR; Mirsadraee S
    Clin Radiol; 2016 Aug; 71(8):768-78. PubMed ID: 27005015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of Cardiac Fibrosis: An Update, From the
    Karur GR; Aneja A; Stojanovska J; Hanneman K; Latchamsetty R; Kersting D; Rajiah PS
    AJR Am J Roentgenol; 2024 Jun; 222(6):e2329870. PubMed ID: 37753860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of Myocardial Contrast-Enhanced T
    Höke U; Khidir MJ; van der Geest RJ; Schalij MJ; Bax JJ; Delgado V; Ajmone Marsan N
    Am J Cardiol; 2017 May; 119(9):1456-1462. PubMed ID: 28274575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping.
    Ferreira VM; Piechnik SK; Robson MD; Neubauer S; Karamitsos TD
    J Thorac Imaging; 2014 May; 29(3):147-54. PubMed ID: 24576837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.
    Rutherford E; Talle MA; Mangion K; Bell E; Rauhalammi SM; Roditi G; McComb C; Radjenovic A; Welsh P; Woodward R; Struthers AD; Jardine AG; Patel RK; Berry C; Mark PB
    Kidney Int; 2016 Oct; 90(4):845-52. PubMed ID: 27503805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of myocardial delayed enhancement with cardiac computed tomography in cardiomyopathies: a prospective comparison with delayed enhancement cardiac magnetic resonance imaging.
    Lee HJ; Im DJ; Youn JC; Chang S; Suh YJ; Hong YJ; Kim YJ; Hur J; Choi BW
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):577-584. PubMed ID: 27873128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease.
    Podlesnikar T; Delgado V; Bax JJ
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):97-112. PubMed ID: 28642994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Employing Extracellular Volume Cardiovascular Magnetic Resonance Measures of Myocardial Fibrosis to Foster Novel Therapeutics.
    Schelbert EB; Sabbah HN; Butler J; Gheorghiade M
    Circ Cardiovasc Imaging; 2017 Jun; 10(6):. PubMed ID: 28512159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Magnetic Resonance in Nonischemic Cardiomyopathies.
    Yang EY; Shah DJ
    Methodist Debakey Cardiovasc J; 2020; 16(2):97-105. PubMed ID: 32670469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T1 and T2 mapping: new perspectives in cardiac magnetic resonance imaging].
    Tessa C; Del Meglio J; Salvatori L; Casolo G
    G Ital Cardiol (Rome); 2014 Nov; 15(11):607-15. PubMed ID: 25424139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis.
    Strauss DG; Selvester RH; Lima JA; Arheden H; Miller JM; Gerstenblith G; Marbán E; Weiss RG; Tomaselli GF; Wagner GS; Wu KC
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):327-36. PubMed ID: 19808427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac T
    Aherne E; Chow K; Carr J
    J Magn Reson Imaging; 2020 May; 51(5):1336-1356. PubMed ID: 31334899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis.
    Giollo A; Dumitru RB; Swoboda PP; Plein S; Greenwood JP; Buch MH; Andrews J
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):1053-1062. PubMed ID: 33057879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority of the extracellular volume fraction over the myocardial T1 value for the assessment of myocardial fibrosis in patients with non-ischemic cardiomyopathy.
    Inui K; Tachi M; Saito T; Kubota Y; Murai K; Kato K; Takano H; Amano Y; Asai K; Shimizu W
    Magn Reson Imaging; 2016 Oct; 34(8):1141-5. PubMed ID: 27215951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel imaging techniques for diffuse myocardial fibrosis.
    Sado DM; Flett AS; Moon JC
    Future Cardiol; 2011 Sep; 7(5):643-50. PubMed ID: 21929344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.